Actinium Pharmaceuticals Series A Warrant

YTD

ALL

Why Robinhood?

You can watch ATNRW and buy or sell other stocks, ETFs, and their options commission-free!

About ATNRW

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients.

CEO

Sandesh Seth, MBA

CEOSandesh Seth, MBA

Employees

—

Employees—

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2000

Founded2000

Employees

—

Employees—

ATNRW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

Actinium Pharmaceuticals Series A Warrant(ATNRW) trades at $0.01.

Actinium Pharmaceuticals Series A Warrant(ATNRW) stock opened on 2025-12-12 at —. The price climbed to — and dipped to —.

Actinium Pharmaceuticals Series A Warrant(ATNRW) shares are trading with a volume of 0.